
Semax
Semax (ACTH 4-7 PGP)
Semax is a synthetic heptapeptide built from the 4-7 fragment of adrenocorticotropic hormone (ACTH), Met-Glu-His-Phe, extended with a Pro-Gly-Pro sequence that slows enzymatic degradation. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. The ACTH(4-7) fragment retains neuroactive properties of ACTH but lacks its hormonal effects on the adrenal glands.
In laboratory research, Semax has been studied primarily for its effects on neurotrophic factors, especially brain-derived neurotrophic factor (BDNF) and its receptor TrkB, in rodent brain tissue, as well as in models of cerebral ischemia, learning and attention. It shares its Pro-Gly-Pro stabilizing motif with Selank, and the two are often studied together.
PhysIQ Peptides supplies Semax as a lyophilized powder, third-party tested for purity and identity, for in vitro and laboratory research use only.
Choose how to buy
You save $1.75 every reship · ≈ $21.29 saved per year
Auto-delivered • Skip or cancel anytime • Never run out
Your first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.
- Purity
- 99%
- Form
- Powder (lyophilized)
- CAS Number
- 80714-61-0
- Molecular Formula
- C37H51N9O10S
- Molecular Weight
- 813.9 g/mol
- Available sizes
- 10mg
Sequence
Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
Also available in blends
Mechanism of Action
Semax does not stimulate cortisol release through the melanocortin-2 receptor as ACTH does. Published rodent studies report rapid increases in BDNF and TrkB expression in the hippocampus and cortex, along with effects on dopaminergic and serotonergic systems and on gene expression in ischemia models. A specific primary receptor has not been definitively identified.
Research Areas
- ●BDNF / TrkB neurotrophic signaling
- ●Cerebral ischemia models
- ●Learning and attention research
- ●ACTH fragment structure–activity studies




